In a Pharmaceutical Technology article, M-Star’s John Thomas, PhD, discusses the use of CFD within the biopharma industry to optimize the scale-up and production of drug products, including COVID-19 vaccines.
CFD-based digital twins enable smart manufacturing and are emerging in different phases of process development, process prediction, decision making, and risk mitigation. A key component in the development of this class of digital twin is the ability to reduce simulation time to achieve near real-time computations at relatively low computational burden.